Core Viewpoint - A securities class action lawsuit has been filed against Zynex, Inc. for alleged misconduct during the Class Period from March 13, 2023, to March 11, 2025 [1][2]. Company Overview - Zynex, Inc. is a medical device company based in Englewood, CO, specializing in electrotherapy devices for pain management and rehabilitation [2]. Allegations and Impact - A report published by medical journal STAT on June 4, 2024, accused Zynex of an "oversupplying scheme," where the company allegedly sent excessive supplies to patients to bill insurers for inflated amounts, leading to insurers removing Zynex from their networks [3]. - Following the publication of the report, Zynex's stock price dropped by $0.50 per share, or 5%, closing at $9.35 on June 4, 2024 [3]. Financial Performance - On March 11, 2025, Zynex reported a significant revenue shortfall for Q4 and the full year of 2024, attributing it to slower payments from certain payers, including a temporary suspension of payments from Tricare as they reviewed prior claims [4]. - The announcement of the revenue shortfall resulted in a drastic decline in Zynex's stock price, which fell by $3.59 per share, or 51%, closing at $3.41 on March 12, 2025 [4].